Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gollamudi

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Physiology|July 1, 1984
Pluronic L-81: a potent inhibitor of the transport of intestinal chylomicronsP Tso, S R Gollamudi
Chirality|January 1, 1991
Chiral resolution of alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene, a novel antiplatelet compoundR Gollamudi, Z X Feng
Chirality|January 1, 1995
Synthesis of stereoisomers of antithrombotic nipecotamidesX Zheng, C Day, R Gollamudi
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1988
Evaluation of corrected loss variance as a visual field index. II. Corrected loss variance in conjunction with mean defect may identify stages of glaucomaS R Gollamudi, P Liao, J Hirsch
Enzyme|January 1, 1983
A new substrate for the measurement of N-acetyltransferase activityR Gollamudi, R J Rackley, J Autian
Enzyme|January 1, 1980
N-Acetyltransferases of rat liver and blood: substrate specificitiesR Gollamudi, B Muniraju, E C Schreiber
Journal of Clinical Pharmacology|August 1, 1979
The influence of dosage form on papaverine bioavailabilityM C Meyer, R Gollamudi, A B Straughn
Journal of Pharmaceutical Sciences|February 1, 1994
Antiplatelet activity of nipecotamides in experimental thrombosis in miceW H Lawrence, R D Howell, R Gollamudi
Biopharmaceutics & Drug Disposition|January 1, 1982
Relative bioavailability of acetazolamide tabletsA B Straughn, R Gollamudi, M C Meyer
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1988
Evaluation of corrected loss variance as a visual field index. I. CLV exceeds RMS in discriminating between glaucoma-suspect patients with no loss of visual sensitivity and normal observersP M Liao, S R Gollamudi, J Hirsch
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Physiology|July 1, 1984
Pluronic L-81: a potent inhibitor of the transport of intestinal chylomicronsP Tso, S R Gollamudi
Chirality|January 1, 1991
Chiral resolution of alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene, a novel antiplatelet compoundR Gollamudi, Z X Feng
Chirality|January 1, 1995
Synthesis of stereoisomers of antithrombotic nipecotamidesX Zheng, C Day, R Gollamudi
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1988
Evaluation of corrected loss variance as a visual field index. II. Corrected loss variance in conjunction with mean defect may identify stages of glaucomaS R Gollamudi, P Liao, J Hirsch
Enzyme|January 1, 1983
A new substrate for the measurement of N-acetyltransferase activityR Gollamudi, R J Rackley, J Autian
Enzyme|January 1, 1980
N-Acetyltransferases of rat liver and blood: substrate specificitiesR Gollamudi, B Muniraju, E C Schreiber
Journal of Clinical Pharmacology|August 1, 1979
The influence of dosage form on papaverine bioavailabilityM C Meyer, R Gollamudi, A B Straughn
Journal of Pharmaceutical Sciences|February 1, 1994
Antiplatelet activity of nipecotamides in experimental thrombosis in miceW H Lawrence, R D Howell, R Gollamudi
Biopharmaceutics & Drug Disposition|January 1, 1982
Relative bioavailability of acetazolamide tabletsA B Straughn, R Gollamudi, M C Meyer
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1988
Evaluation of corrected loss variance as a visual field index. I. CLV exceeds RMS in discriminating between glaucoma-suspect patients with no loss of visual sensitivity and normal observersP M Liao, S R Gollamudi, J Hirsch
Pageof 4